Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Gastroenterology

Treatment Strategies: Intestinal Rehabilitation and HPN

At a Glance

Treating Chronic Intestinal Failure focuses on intestinal rehabilitation to maximize nutrient absorption. While Home Parenteral Nutrition (HPN) delivers daily nutrients via IV, therapies like specific diets, GLP-2 medications, and specialized surgery aim to reduce your dependence on HPN over time.

Treating Chronic Intestinal Failure (CIF) is no longer just about “getting through the day”—it is about active Intestinal Rehabilitation. This is a proactive process where a multidisciplinary team uses medicine, diet, and sometimes surgery to help your remaining intestine work better [1][2]. The ultimate goal is to reach enteral autonomy, which is the ability to maintain your health through eating and drinking without IV support. Importantly, this does not mean “eating and drinking normally” like you did before; it often involves highly specialized diets and specific Oral Rehydration Solutions (ORS) instead of regular water or sodas [1][3].

The Foundation: Home Parenteral Nutrition (HPN)

For most people with CIF, Home Parenteral Nutrition (HPN) is the “gold standard” life-sustaining therapy [4]. HPN is a complex mixture of proteins, fats, carbohydrates, vitamins, and minerals delivered directly into your bloodstream [5].

  • The Physical Reality: Rather than being hooked up 24/7, most patients run their HPN for 12 to 15 hours overnight while they sleep [6][7]. You will store your custom IV bags in a dedicated refrigerator and use a portable pump that can be carried in a specialized backpack, allowing you to move around freely during the day.
  • Customization is Key: Your HPN formula should be tailored specifically to you. Your team monitors your blood levels of vitamins, minerals, and organ function markers to adjust your “recipe” [8][9].
  • Safety First: Because the catheter goes directly to your heart, preventing catheter-related bloodstream infections (CRBSI) is a top priority of your care [10][11].

First-Line Medical Management

Before exploring advanced therapies or surgery, your team will optimize your gut’s ability to absorb using foundational medical strategies:

  • Specialized Diets and ORS: Regular water can actually pull fluid out of your body if you have short bowel syndrome. You will be prescribed specific Oral Rehydration Solutions (ORS) that are absorbed more effectively [1].
  • Medications: Your team will likely use anti-motility agents (like loperamide) to slow down the passage of food, giving your gut more time to absorb nutrients, and anti-secretory medications (like PPIs) to reduce the volume of fluid your stomach produces [3][2].

Boosting Adaptation: GLP-2 Analogs

The body naturally tries to adapt after losing part of the intestine. Modern medicine can now “boost” this natural process using GLP-2 analogs, such as teduglutide [12][13].

These medications act as “growth factors” for the gut. They stimulate the cells in your intestinal lining to grow taller and live longer, which increases the total surface area available to absorb nutrients [14][15]. For many patients, these medications can significantly reduce the volume of HPN needed, and some patients may even be able to stop HPN entirely [16][17].

Surgical Pathways to Rehabilitation

If your intestine is not absorbing enough despite medical and dietary changes, specialized surgeries may be an option. These are known as autologous intestinal reconstruction—using your own tissue to improve your gut [18][19].

  • STEP Procedure: The Serial Transverse Enteroplasty Procedure (STEP) is used when the remaining intestine has become “dilated” (stretched out and baggy). Surgeons make a series of precise cuts to create a longer, narrower “zigzag” path, which increases the time food stays in the gut and expands the absorptive surface area [18][20].
  • Intestinal Transplantation: This is a major surgery reserved for when HPN is no longer a safe option—for example, if a patient has severe liver disease from the IV nutrition or has lost access to their central veins [21][22]. Please note that your team will proactively protect your veins through careful monitoring (see Managing Complications and Long-Term Monitoring), so this step is a last resort, not an inevitability.

Common questions in this guide

What is intestinal rehabilitation?
Intestinal rehabilitation is a proactive treatment process that uses medicine, diet, and sometimes surgery to help your remaining intestine absorb nutrients better. The ultimate goal is to reduce your need for IV nutrition and help you maintain your health through specialized diets and fluids.
How does Home Parenteral Nutrition (HPN) work?
Home Parenteral Nutrition is a custom liquid mixture of nutrients delivered directly into your bloodstream through a central catheter. Most patients run their HPN for 12 to 15 hours overnight using a portable pump, allowing them to move freely during the day.
How do GLP-2 analogs like teduglutide help intestinal failure?
GLP-2 analogs act as growth factors for your gut. They stimulate the cells in your intestinal lining to grow, which increases the surface area available to absorb nutrients and can safely reduce your reliance on HPN.
What is the STEP procedure?
The Serial Transverse Enteroplasty Procedure (STEP) is a specialized surgery used when the remaining intestine has become stretched out. Surgeons create a longer, narrower zigzag path to increase the time food stays in the gut, boosting nutrient absorption.
When is an intestinal transplant necessary?
Intestinal transplantation is a major surgery generally reserved as a last resort when HPN is no longer a safe option. This typically occurs if a patient develops severe liver disease from the IV nutrition or has lost access to their central veins.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my HPN formula 'customized' for my specific bloodwork and nutrient needs, or am I using a standardized formula?
  2. 2.What is our 'intestinal rehabilitation' plan, and what specific goals are we trying to reach in the next six months?
  3. 3.Am I a candidate for GLP-2 analogs like teduglutide to help my gut adapt more effectively?
  4. 4.If my bowel is dilated, would a STEP procedure (Serial Transverse Enteroplasty) help increase my absorptive surface area?
  5. 5.What specific criteria would cause us to evaluate intestinal transplantation, and how can we proactively protect my veins to avoid that?
  6. 6.Are we optimizing my first-line medical therapies with the right ORS and anti-motility agents?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Pediatric Intestinal Failure: A Review of the Scope of Disease and a Regional Model of a Multidisciplinary Care Team.

    Mangalat N

    Missouri medicine 2019; (116(2)):129-133.

    PMID: 31040499
  2. 2

    Multidisciplinary Management in Pediatric Ultrashort Bowel Syndrome.

    Belza C, Wales PW

    Journal of multidisciplinary healthcare 2020; (13()):9-17 doi:10.2147/JMDH.S236130.

    PMID: 32021230
  3. 3

    [Intestinal failure due to short bowel syndrome: impact of a multidisciplinary intestinal rehabilitation program].

    Molina ME, Bellolio F, Klaassen J, et al.

    Revista medica de Chile 2016; (144(11)):1410-1416 doi:10.4067/S0034-98872016001100006.

    PMID: 28394957
  4. 4

    ESPEN guideline on chronic intestinal failure in adults - Update 2023.

    Pironi L, Cuerda C, Jeppesen PB, et al.

    Clinical nutrition (Edinburgh, Scotland) 2023; (42(10)):1940-2021 doi:10.1016/j.clnu.2023.07.019.

    PMID: 37639741
  5. 5

    Definitions of intestinal failure and the short bowel syndrome.

    Pironi L

    Best practice & research. Clinical gastroenterology 2016; (30(2)):173-85.

    PMID: 27086884
  6. 6

    Cyclic infusion mitigates liver dysfunction associated with continuous total parenteral nutrition in a novel murine model.

    Willis NB, Mims TS, Antunes K, et al.

    American journal of physiology. Gastrointestinal and liver physiology 2025; (329(4)):G536-G545 doi:10.1152/ajpgi.00033.2025.

    PMID: 40789651
  7. 7

    New Insights Into Intestinal Failure-Associated Liver Disease in Children.

    Khalaf RT, Sokol RJ

    Hepatology (Baltimore, Md.) 2020; (71(4)):1486-1498 doi:10.1002/hep.31152.

    PMID: 32003009
  8. 8

    Long-term home parenteral nutrition and profile of amino acids in serum and their loss in urine.

    Dastych M, Šenkyřík M, Mikušková A, Dastych M

    The British journal of nutrition 2023; (129(9)):1537-1542 doi:10.1017/S0007114522002008.

    PMID: 35912675
  9. 9

    Vitamin D deficiency in patients with chronic intestinal failure on home parenteral nutrition.

    Rondaij T, Kozjek NR, Popovič P, Jordan T

    Clinical nutrition ESPEN 2021; (42()):258-261 doi:10.1016/j.clnesp.2021.01.026.

    PMID: 33745589
  10. 10

    Vascular rehabilitation in children with chronic intestinal failure reduces the risk of central-line associated bloodstream infections and catheter replacements.

    Hilberath J, Sieverding L, Urla C, et al.

    Clinical nutrition (Edinburgh, Scotland) 2024; (43(7)):1636-1641 doi:10.1016/j.clnu.2024.05.026.

    PMID: 38801807
  11. 11

    Mechanical Complications in Central Lines Using Taurolidine Versus Ethanol Lock Therapy in Children With Intestinal Failure.

    Strauss J, Boctor DL, Silverman JA, Casey L

    Journal of pediatric gastroenterology and nutrition 2022; (74(6)):776-781 doi:10.1097/MPG.0000000000003434.

    PMID: 35213858
  12. 12

    Teduglutide for treatment of adult patients with short bowel syndrome.

    Billiauws L, Bataille J, Boehm V, et al.

    Expert opinion on biological therapy 2017; (17(5)):623-632 doi:10.1080/14712598.2017.1304912.

    PMID: 28293969
  13. 13

    Nutritional management of a patient with chronic intestinal failure and hemodialysis receiving teduglutide: A case report.

    Florencio Ojeda L, Domínguez Rabadán R, Laínez López M, et al.

    Nutrition (Burbank, Los Angeles County, Calif.) 2023; (113()):112137 doi:10.1016/j.nut.2023.112137.

    PMID: 37481817
  14. 14

    Pathophysiology of gastrointestinal acute graft-versus-host disease and the potential role of glucagon-like peptide 2.

    Zeiser R, Chen YB, Youssef NN, Ayuk F

    British journal of haematology 2023; (201(4)):620-627 doi:10.1111/bjh.18778.

    PMID: 36965050
  15. 15

    Treatment of short bowel syndrome: Breaking the therapeutic ceiling?

    Wauters L, Joly F

    Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2023; (38 Suppl 1()):S76-S87 doi:10.1002/ncp.10974.

    PMID: 37115030
  16. 16

    Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome.

    Lambe C, Talbotec C, Kapel N, et al.

    The American journal of clinical nutrition 2023; (117(6)):1152-1163 doi:10.1016/j.ajcnut.2023.02.019.

    PMID: 37270289
  17. 17

    Three-year experience with GLP-2 analog in intestinal rehabilitation for pediatric-onset short bowel syndrome.

    Tazuke Y, Kimura T, Ueno T, et al.

    Pediatric surgery international 2025; (41(1)):273 doi:10.1007/s00383-025-06154-z.

    PMID: 40875041
  18. 18

    Nutritional Care for Patients with Intestinal Failure.

    Matarese LE, Harvin G

    Gastroenterology clinics of North America 2021; (50(1)):201-216 doi:10.1016/j.gtc.2020.10.004.

    PMID: 33518165
  19. 19

    Autologous intestinal reconstruction: a single institution study of the serial transverse enteroplasty (STEP) and the longitudinal intestinal lengthening and tailoring (LILT).

    Shah AA, Petrosyan M, Franklin AL, et al.

    Pediatric surgery international 2019; (35(6)):649-655 doi:10.1007/s00383-019-04468-3.

    PMID: 30868210
  20. 20

    Serial Transverse Duodenal Enteroplasty in Adults With Ultra-Short Bowel Syndrome: A Case Series.

    Ramírez-Arbeláez JA, Orjuela R, Ramirez A, et al.

    Cureus 2025; (17(4)):e83145 doi:10.7759/cureus.83145.

    PMID: 40438799
  21. 21

    Intestinal transplantation in children: current status.

    Martinez Rivera A, Wales PW

    Pediatric surgery international 2016; (32(6)):529-40 doi:10.1007/s00383-016-3885-2.

    PMID: 27033524
  22. 22

    Surgeon's perspective on short bowel syndrome: Where are we?

    Marino IR, Lauro A

    World journal of transplantation 2018; (8(6)):198-202 doi:10.5500/wjt.v8.i6.198.

    PMID: 30370230

This information about intestinal failure treatments and HPN is for educational purposes only. Always consult your gastroenterologist or nutrition support team to design a safe, customized rehabilitation plan for your specific needs.

Get notified when new evidence is published on Chronic intestinal failure.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.